Gene study could personalize diabetes treatment
NCT ID NCT06256419
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 26 times
Summary
This study looks at how certain genes influence the effectiveness of common diabetes drugs like exenatide and liraglutide in people with type 2 diabetes. Researchers will analyze blood samples and health data from 300 participants to find genetic markers that predict better blood sugar and weight control. The goal is to help doctors choose the right medication for each patient based on their genetic makeup.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China, Jiangsu, Department of Endocrinology
RECRUITINGXuzhou, China, 221006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.